MMWR Recomm Rep. 1993 Aug 6;42(RR-12):1-39.
In 1985, CDC published Policy Guidelines for Prevention and Control of Chlamydia trachomatis infections. Those guidelines highlighted the prevalence and morbidity of chlamydial infections and stressed the need to include antibiotics effective against chlamydia when treating patients for urethritis, mucopurulent cervicitis, and pelvic inflammatory disease. The recommendations presented in this report update the 1985 guidelines. In addition, these recommendations propose a national strategy for reducing the morbidity of chlamydial infections by detection and treatment and through the prevention of transmission to uninfected persons. Such an effort is now possible because of a) expanding educational efforts stimulated by the epidemic of acquired immunodeficiency syndrome and other sexually transmitted diseases, and b) the availability of chlamydia tests that are easy to use, economical, and accurate, thereby allowing health-care providers to diagnose and treat infected persons and their sex partners. Education, screening, and sex partner referral require coordination of the activities of several professionals, including educators, clinicians, microbiologists, outreach workers, and program managers. Because chlamydial infections are common among adolescents and young adults throughout the United States, health-care providers and other agencies serving these groups should become more involved if a sufficiently large proportion of the chlamydia-infected population is to be reached. Health departments should establish consortia of these organizations to pool resources and to coordinate activities. To facilitate such collaborations, this document outlines the elements of a chlamydia prevention program. These recommendations were developed by CDC after consultation with experts attending a chlamydia prevention workshop held in Atlanta, Georgia, March 26-28, 1991. Commentary from additional public health, medical, and laboratory practitioners also was considered in developing these recommendations.
1985年，美国疾病控制与预防中心（CDC）发布了沙眼衣原体感染预防与控制政策指南。这些指南强调了衣原体感染的患病率和发病率，并强调在治疗尿道炎、黏液脓性宫颈炎和盆腔炎患者时，需要使用对衣原体有效的抗生素。本报告中的建议更新了1985年的指南。此外，这些建议提出了一项国家战略，通过检测和治疗以及预防传播给未感染者来降低衣原体感染的发病率。由于以下原因，现在开展这样的工作成为可能：a）由获得性免疫缺陷综合征和其他性传播疾病的流行所激发的教育工作不断扩大；b）有易于使用、经济且准确的衣原体检测方法，从而使医疗保健提供者能够诊断和治疗感染者及其性伴侣。教育、筛查和性伴侣转诊需要包括教育工作者、临床医生、微生物学家、外展工作者和项目管理人员在内的多个专业人员的活动进行协调。由于衣原体感染在美国青少年和年轻人中很常见，如果要覆盖足够比例的衣原体感染人群，服务于这些群体的医疗保健提供者和其他机构应更多地参与进来。卫生部门应建立这些组织的联盟，以集中资源并协调活动。为促进此类合作，本文件概述了衣原体预防计划的要素。这些建议是CDC在与参加1991年3月26日至28日在佐治亚州亚特兰大举行的衣原体预防研讨会的专家协商后制定的。在制定这些建议时，还考虑了其他公共卫生、医学和实验室从业人员的意见。
